Found: 14
Select item for more details and to access through your institution.
Challenges and developments in universal vaccine design against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00597-4
- By:
- Publication type:
- Article
Spatio-temporal spread and evolution of Lassa virus in West Africa.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09200-8
- By:
- Publication type:
- Article
Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology.
- Published in:
- Veterinary Research, 2021, v. 52, n. 1, p. 1, doi. 10.1186/s13567-021-00939-5
- By:
- Publication type:
- Article
RBD<sub>206</sub>-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01065-0
- By:
- Publication type:
- Article
Relative Quantitative Proteomic Analysis of Brucella abortus Reveals Metabolic Adaptation to Multiple Environmental Stresses.
- Published in:
- Frontiers in Microbiology, 2017, p. 1, doi. 10.3389/fmicb.2017.02347
- By:
- Publication type:
- Article
Rational design of a single-component mRNA vaccine against orthopoxvirus and SARS-CoV-2.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Rapid Identification of Brucella Genus and Species In Silico and On-Site Using Novel Probes with CRISPR/Cas12a.
- Published in:
- Microorganisms, 2024, v. 12, n. 5, p. 1018, doi. 10.3390/microorganisms12051018
- By:
- Publication type:
- Article
A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M.
- Published in:
- BMC Genomics, 2017, v. 18, p. 1, doi. 10.1186/s12864-017-3800-9
- By:
- Publication type:
- Article
Toll‐like receptor 4 signalling regulates antibody response to adenoviral vector‐based vaccines by imprinting germinal centre quality.
- Published in:
- Immunology, 2018, v. 155, n. 2, p. 251, doi. 10.1111/imm.12957
- By:
- Publication type:
- Article
Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
- Published in:
- Toxins, 2016, v. 8, n. 3, p. 56, doi. 10.3390/toxins8030056
- By:
- Publication type:
- Article
Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, p. 1, doi. 10.3389/fcimb.2023.1180344
- By:
- Publication type:
- Article
Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirusvectored vaccines.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, p. 1, doi. 10.3389/fcimb.2023.1195314
- By:
- Publication type:
- Article
Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 4, p. 480, doi. 10.3390/v12040480
- By:
- Publication type:
- Article